PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 217 filers reported holding PTC THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,285 | -69.1% | 236 | -44.1% | 0.00% | – |
| Q2 2023 | $17,104 | -36.7% | 422 | -24.2% | 0.00% | – |
| Q1 2023 | $27,015 | +93.0% | 557 | +54.7% | 0.00% | – |
| Q4 2022 | $14,000 | -39.1% | 360 | -21.6% | 0.00% | – |
| Q3 2022 | $23,000 | 0.0% | 459 | -21.7% | 0.00% | – |
| Q2 2022 | $23,000 | -25.8% | 586 | -29.5% | 0.00% | – |
| Q1 2022 | $31,000 | +6.9% | 831 | +11.8% | 0.00% | – |
| Q4 2021 | $29,000 | +31.8% | 743 | +24.5% | 0.00% | – |
| Q3 2021 | $22,000 | 0.0% | 597 | +13.5% | 0.00% | – |
| Q2 2021 | $22,000 | -31.2% | 526 | -20.2% | 0.00% | – |
| Q1 2021 | $32,000 | -22.0% | 659 | -2.2% | 0.00% | – |
| Q4 2020 | $41,000 | -25.5% | 674 | -43.3% | 0.00% | – |
| Q3 2020 | $55,000 | -11.3% | 1,188 | -3.4% | 0.00% | – |
| Q2 2020 | $62,000 | +21.6% | 1,230 | +7.8% | 0.00% | – |
| Q1 2020 | $51,000 | – | 1,141 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ayer Capital Management, LP | 416,666 | $7,153,000 | 38.92% |
| Novo Holdings A/S | 747,359 | $11,210,000 | 2.78% |
| Bain Capital Public Equity Management, LLC | 2,333,333 | $50,073,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,027 | $18,134,000 | 0.84% |
| HealthCor Management, L.P. | 732,200 | $15,713,000 | 0.84% |
| RA Capital Management | 300,000 | $6,438,000 | 0.67% |
| Catalyst Capital Advisors LLC | 30,666 | $658,000 | 0.36% |
| CR Intrinsic Investors, LLC | 119,237 | $2,559,000 | 0.08% |
| Weiss Multi-Strategy Advisers LLC | 284,130 | $6,098,000 | 0.07% |
| SECTORAL ASSET MANAGEMENT INC | 57,519 | $1,234,000 | 0.06% |